@claudio_vagnoni's HGH and peptide claims, fact-checked

What does this video actually claim?

Claudio Vagnoni argues that peptides like tesamorelin and ipamorelin don't work as advertised, while direct HGH and IGF-1 injections "change everything" for muscle building and body composition. His caption suggests peptides are overhyped compared to actual growth hormone therapy.

This is a common debate in fitness circles. Peptides are supposed to stimulate your body's natural HGH production, while synthetic HGH bypasses that system entirely. Vagnoni's essentially saying the indirect approach fails while the direct route succeeds.

Does the science actually support this take?

The research on growth hormone-releasing peptides shows modest but real effects, contradicting Vagnoni's dismissal. The GHRP-2 study by Bowers et al. (Journal of Clinical Endocrinology & Metabolism, 1999) found ipamorelin increased HGH levels by 13-fold in healthy adults.

Tesamorelin specifically showed 15.2% reduction in visceral fat in HIV patients over 26 weeks (Falutz et al., Lancet, 2010). That's not nothing. Meanwhile, synthetic HGH does produce more dramatic results but comes with serious side effects including joint pain, fluid retention, and increased diabetes risk.

The GHDEF study (Götherström et al., Journal of Clinical Endocrinology & Metabolism, 2005) found 1.33mg daily HGH increased lean body mass by 4.6kg over 2 years in deficient adults.

What did Vagnoni get wrong about peptides?

Calling peptides ineffective oversimplifies the evidence. Ipamorelin at 0.3mg three times daily increased IGF-1 levels by 35% without affecting cortisol in the Johansen study (Growth Hormone & IGF Research, 1999).

CJC-1295 combined with ipamorelin raised HGH levels for up to 6 days per injection according to Teichman et al. (Clinical Endocrinology, 2006). These aren't placebo-level effects. The issue isn't that peptides don't work, it's that they work more subtly than direct hormone injection.

Vagnoni also ignores the safety profile difference. Peptides rarely cause the severe side effects seen with synthetic HGH, making them more practical for healthy adults seeking modest improvements.

What about his HGH enthusiasm?

Vagnoni's right that synthetic HGH produces more dramatic changes, but he's glossing over the downsides. The Liu et al. meta-analysis (Annals of Internal Medicine, 2007) found HGH increased lean mass by 4.6kg but also caused joint pain in 23% of users and fluid retention in 35%.

More concerning, the French SAGhE study (Journal of Clinical Endocrinology & Metabolism, 2012) found increased mortality risk in adults who received HGH as children. The long-term safety data for healthy adults using HGH isn't reassuring.

Plus there's the legal issue. HGH requires a prescription for legitimate medical conditions. Using it for bodybuilding purposes puts users in legal and medical gray areas that Vagnoni doesn't address.

What should you actually know?

Both peptides and HGH can affect body composition, but neither is a magic solution for fitness goals. The Blackman et al. study (JAMA, 2002) found that while HGH increased lean mass, it didn't improve strength or function in healthy older men.

If you're considering either option, peptides offer a gentler approach with fewer side effects, while HGH provides more dramatic results with greater risks. Neither replaces proper training and nutrition, which remain the foundation of any physique goals.

The most honest take? Peptides work modestly, HGH works more dramatically, and both come with tradeoffs Vagnoni's post doesn't fully explore.